This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IPO Comeback In 2009 Sets Stage For Busy 2010

In the U.S., the top three performers in 2009 were out of China: water-treatment equipment maker Duoyuan Global Water Inc., online gaming company Ltd. and Lihua International Inc., which makes magnet wire and fine copper for use in electronics. All have at least doubled from their offering price.

Specialty chemicals maker Chemspec International Ltd. and clinical stage biotechnology company Omeros Corp. earned the dubious distinction of biggest losers among 2009 IPOs, each having fallen about 27 percent from their offering price. Chemspec, which went public in June, lowered its fiscal 2009 outlook due to low global demand. Omeros fell as it received no Food and Drug Administration approvals.

Among the biggest disappointments of 2009 was Rosetta Stone Inc., which debuted in April rising nearly 40 percent on its first trading day. The seller of language learning software canceled a secondary public stock offering in August, and in November said its U.S. consumer business was showing signs of weakness. The stock ended the year just 5 cents off its offering price of $18.

How well a company did this year seemed to mostly depend on timing and profitability, Gaskins said. Looking forward, there aren't any oil and gas companies in a position to list, he said, though there may be a few spin-offs of those that have already gone public. Meanwhile, the solar sector isn't expected to shine in the IPO market next year as supply exceeds demand.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LIWA $0.01 -46.96%
CYOU $19.88 -1.20%
EBAY $24.26 -0.70%
OMER $13.25 0.00%
RST $8.02 0.88%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs